Kolinpharma SpA
MIL:KIP

Watchlist Manager
Kolinpharma SpA Logo
Kolinpharma SpA
MIL:KIP
Watchlist
Price: 9.9 EUR
Market Cap: €16.2m

Wall Street
Price Targets

KIP Price Targets Summary
Kolinpharma SpA

There are no price targets for KIP.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Kolinpharma SpA Competitors:
Price Targets
ZEN
Zen Corporation Group PCL
5% Upside
MAC
Macerich Co
6% Upside

Revenue
Forecast

33% / Year
Past Growth
12% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss
33% / Year
Past Growth
12% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss

For the last 6 years the compound annual growth rate for Kolinpharma SpA's revenue is 33%. The projected CAGR for the next 3 years is 12%.

Operating Income
Forecast

N/A
Past Growth
28% / Year
Estimated Growth
Estimates Accuracy
1%
Average Beat
N/A
Past Growth
28% / Year
Estimated Growth
Estimates Accuracy
1%
Average Beat

The compound annual growth rate of Kolinpharma SpA's operating income for the next 3 years is 28%.

Net Income
Forecast

N/A
Past Growth
52% / Year
Estimated Growth
Estimates Accuracy
-11%
Average Miss
N/A
Past Growth
52% / Year
Estimated Growth
Estimates Accuracy
-11%
Average Miss

The compound annual growth rate of Kolinpharma SpA's net income for the next 3 years is 52%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is KIP's stock price target?
Not Available

KIP doesn't have any price targets made by Wall Street professionals.

What is Kolinpharma SpA's Revenue forecast?
Projected CAGR
12%

For the last 6 years the compound annual growth rate for Kolinpharma SpA's revenue is 33%. The projected CAGR for the next 3 years is 12%.

What is Kolinpharma SpA's Operating Income forecast?
Projected CAGR
28%

The compound annual growth rate of Kolinpharma SpA's operating income for the next 3 years is 28%.

What is Kolinpharma SpA's Net Income forecast?
Projected CAGR
52%

The compound annual growth rate of Kolinpharma SpA's net income for the next 3 years is 52%.

Back to Top